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Septins	 are	 guanine	 nucleotide	 binding	 proteins	 that	 are	 conserved	 from	 fungi	 to	
humans.	 Septins	 assemble	 into	 hetero-oligomeric	 complexes	 and	 higher-order	
structures	 with	 key	 roles	 in	 various	 cellular	 functions	 including	 cell	 migration	 and	
division.	 The	 mechanisms	 by	 which	 septins	 assemble	 and	 interact	 with	 other	
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cytoskeletal	elements	like	actin	remain	elusive.	A	powerful	approach	to	address	this	
question	 is	 by	 cell-free	 reconstitution	 of	 purified	 cytoskeletal	 proteins	 combined	
with	fluorescence	microscopy.	Here,	we	describe	procedures	for	the	purification	of	
recombinant	 Drosophila	 and	 human	 septin	 hexamers	 from	 Escherichia	 coli	 and	





Since	 their	 discovery	 in	 budding	 yeast	more	 than	 forty	 years	 ago	 (Hartwell,	 1971;	
Hartwell,	 Culotti,	 Pringle,	 &	 Reid,	 1974),	 septin	 GTP-binding	 proteins	 have	 been	
shown	 to	be	present	 in	all	 eukaryotes	except	plants	 (Nishihama,	Onishi,	&	Pringle,	
2011;	 Pan,	 Malmberg,	 &	 Momany,	 2007).	 Although	 several	 groups	 encountered	
mammalian	 septin	 genes	 during	 their	 studies	 in	 the	 early	 1990s	 (for	 example,	
(Nakatsuru,	Sudo,	&	Nakamura,	1994)),	the	 identification	and	functional	analysis	of	
Drosophila	 septins	 (Fares,	 Peifer,	 &	 Pringle,	 1995;	 Neufeld	 &	 Rubin,	 1994)	
established	 that	 septin	 family	 proteins	 existed	 in	 animals	 and	 not	 only	 in	 budding	
yeast,	 and	 also	 provided	 strong	 evidence	 for	 roles	 of	 septins	 not	 related	 to	
cytokinesis.	 Soon	 after	 came	 the	 first	 isolation	 of	 native	 septin	 complexes	 from	
Drosophila	embryonic	extracts	using	an	immunoaffinity	approach	(Field	et	al.,	1996),	
which	 provided	 the	 first	 evidence	 that	 septin	 heteromeric	 complexes	 are	 able	 to	
polymerize	 into	 filaments	 in	 vitro.	 This	 study	 was	 followed	 by	 the	 isolation	 of	





new	 protocol	 was	 reported	 for	 the	 purification	 of	 endogenous	 septin	 complexes	




filaments	necessitated	 the	 co-expression	of	 septins	 in	heterologous	 systems.	 Thus,	






(Kinoshita	 et	 al.,	 2002),	 C.	 elegans	 septin	 complexes	 from	bacteria	 and	 insect	 cells	
(John	 et	 al.,	 2007),	 and	 Drosophila	 septin	 complexes	 were	 also	 expressed	 in	 and	
purified	from	bacteria	(Huijbregts	et	al.,	2009;	Mavrakis	et	al.,	2014)	and	insect	cells	
(Huijbregts	 et	 al.,	 2009).	 Biochemical	 analysis	 and	 electron	 microscopy	 of	 the	
purified	 recombinant	 complexes	 in	 these	 studies,	 as	well	 as	 of	mammalian	 septin	
complexes	 immuno-purified	 (Sellin,	 Sandblad,	 Stenmark,	 &	 Gullberg,	 2011)	 or	
affinity-purified	(Kim,	Froese,	Estey,	&	Trimble,	2011)	from	mammalian	cell	cultures,	
together	 with	 the	 crystal	 structure	 of	 a	 human	 septin	 complex	 (Sirajuddin	 et	 al.,	
2007),	have	altogether	established	that	septins	from	all	organisms	form	rod-shaped	
complexes	 containing	 two,	 three	 or	 four	 septins	with	 each	 present	 in	 two	 copies,	






for	 deciphering	 how	 septin	 protomers	 assemble	 into	 filaments	 and	 how	 filaments	
organize	into	higher-order	structures.	The	main	drawback	of	EM	approaches	is	that	
they	 provide	 snapshots	 of	 septin	 organization	 and	 do	 not	 allow	 studies	 on	 how	
freely-diffusing	 septin	 protomers	 dynamically	 assemble,	 grow	 and	 organize	 into	







of	 a	 specific	 septin	 subunit	with	 a	 fluorescent	protein,	 such	as	mEGFP	or	mCherry	
(Bridges	 et	 al.,	 2014;	 Sadian	 et	 al.,	 2013),	 (2)	 genetic	 fusion	 of	 a	 specific	 septin	







The	 mechanisms	 that	 control	 septin	 assembly	 into	 complexes	 and	 higher-order	
filamentous	structures	and	the	regulation	of	septin	structures	and	their	dynamics	are	
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still	 largely	 unclear.	 Especially	 little	 in	 vitro	 work	 has	 been	 done	 on	 human	 and	
Drosophila	septins,	so	it	remains	unknown	how	animal	septin	assembly	differs	from	
budding	 yeast	 septin	 assembly.	 In	 addition,	 septin	 interactions	 with	 other	
cytoskeletal	 components	 remain	 elusive.	 Here,	 we	 describe	 procedures	 to	 purify	
recombinant	 Drosophila	 and	 human	 septin	 hexamers	 from	 Escherichia	 coli.	 We	
describe	 procedures	 for	 fluorescent	 tagging	 (using	 either	 genetic	 GFP	 fusions	 or	
chemical	 conjugation	 with	 organic	 dyes),	 and	 provide	 protocols	 for	 in	 vitro	
reconstitution	 of	 actin	 and	 septin	 assembly	 in	 surface	 assays	 amenable	 to	 high-
resolution	imaging	by	TIRF	microscopy.		
	
1.	 Cloning	 strategy	 for	 recombinant	 septin	 complex	 production	 in	
bacteria	
To	 isolate	 stoichiometric	 hexameric	 septin	 complexes	 we	 combine	 the	 extended	
pET-MCN	(pET	Multi-Cloning	and	expressioN)	series	as	a	septin	co-expression	system	
(Diebold,	 Fribourg,	 Koch,	 Metzger,	 &	 Romier,	 2011)	 with	 a	 two-tag	 purification	
scheme.	To	this	end,	we	use	two	vectors,	pnEA-vH	and	pnCS.	pnEA-vH	harbors	the	
central	 subunit	of	 the	hexamer	 (DSep1	 for	Drosophila	 septins	or	hSep2	 for	human	
septins)	under	the	control	of	the	T7	promoter,	with	a	TEV-cleavable	6xHis-tag	fused	
to	 its	N-terminus.	pnCS	harbors	the	other	two	septin	genes	(DSep2	and	Peanut	 for	
Drosophila	 septins,	or	hSep6	and	hSep7	 for	human	septins)	under	 the	control	of	a	
single	T7	promoter	(Figure	1).	Using	appropriate	PCR	primers	we	fuse	the	C-terminus	
of	 the	 terminal	 subunit	 of	 the	 hexamer	 (Pnut	 for	 Drosophila	 septins	 or	 hSep7	 for	
human	 septins)	 to	 a	 noncleavable	 eight-amino-acid	 Strep-tag	 II	 (WSHPQFEK,	 1058	
Da).		
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To	 generate	 the	 pnCS	 vector	 harboring	 two	 septin	 genes	 under	 the	 control	 of	 a	
single	 promoter,	 we	 use	 bidirectional	 cloning	 to	 concatenate	 two	 pnCS	 vectors	
encoding	one	 septin	 gene	each.	 Each	 septin	 gene	 in	 the	pnCS	 vector	 is	 flanked	by	
SpeI	on	 the	5'	 side	of	 the	MCS	and	by	XbaI	on	 the	3'	 side.	Using	 standard	 cloning	
procedures	 (Green	 &	 Sambrook,	 2012)	 we	 double-digest	 the	 donor	 plasmid	 with	
SpeI	/	XbaI,	ligate	the	insert	to	SpeI-digested	acceptor	plasmid	and	select	the	clones	
with	the	correct	insert	orientation	using	restriction	analysis	(Figure	1).	
We	 have	 used	 this	 strategy	 for	 successful	 coexpression	 of	 both	 Drosophila	 and	
human	septin	hexamers.	The	flexibility	of	the	pET-MCN	series	(detailed	in	(Diebold	et	
al.,	2011))	enables	rapid	screening	to	test	how	the	position	of	the	tags,	the	order	of	





pnCS	 vectors	 of	 the	 pET-MCN	 series	 (Diebold	 et	 al.,	 2011).	 Here	 this	 strategy	 is	 used	 for	 the	




We	 co-express	 His6-hSep2,	 hSep6	 and	 hSep7-Strep	 for	 producing	 human	 septin	
























We	 use	 standard	 procedures	 (Green	 &	 Sambrook,	 2012)	 to	 co-transform	 E.coli	














The	 C-termini	 of	 both	 Peanut	 (when	 co-expressed	with	 DSep1	 and	 DSep2)	 and	 of	
hSep7	 (when	 co-expressed	 with	 hSep2	 and	 hSep6)	 are	 prone	 to	 degradation	 by	
bacterial	proteases	during	protein	expression	(Mavrakis	et	al.,	2014).	The	presence	
of	 the	 Strep-tag	 II	 helps	 isolate	 complexes	 containing	 full-length	 Pnut/hSep7.	 To	
minimize	 degradation,	 we	 developed	 a	 protocol	 whereby	 each	 bacterial	 cell	
produces	 less	 protein	 (short	 induction	 time)	 but	 with	 less	 degradation.	 We	
compensate	 for	 the	 smaller	 protein	 yield	 per	 cell	 by	 using	 Terrific	 Broth	 to	 grow	
bacteria	 at	 37°C	 to	 a	 high	 density	 before	 induction.	We	 typically	 prepare	 6-8	 L	 of	
culture.				




















4.	 Induce	 protein	 expression	 by	 adding	 IPTG	 to	 0.5	mM	 final.	 Allow	 cells	 to	 grow	
overnight	(16	h)	at	17°C.	
5.	 Collect	 and	 store	 bacterial	 pellets	 as	 described	 for	 dark	 septin	 production.	 The	
pellets	should	be	yellow-greenish	confirming	the	presence	of	GFP.	
	
3.	 Purification	 and	 characterization	 of	 recombinant	 septin	 complexes	
from	bacteria	
We	 use	 a	 two-tag	 purification	 scheme	 (His6-tag	 on	 the	 central	 subunit	 i.e.	
DSep1/hSep2	and	a	Strep-tag	II	on	the	terminal	subunit	i.e.	Pnut/hSep7)	in	order	to	
select	 for	 complexes	 with	 full-length	 Pnut/hSep7	 and	 to	 minimize	 isolation	 of	
substoichiometric	 septin	 complexes	 (Figure	 2).	 The	 nickel	 affinity	 column	 isolates	
His6-DSep1/hSep2-containing	 complexes,	 whereas	 the	 Strep-Tactin	 (engineered	
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streptavidin)	 affinity	 column	 further	 isolates	 those	 complexes	 that	 also	 contain	
Pnut/hSep7-Strep	 thus	 heterohexamers.	 A	 final	 gel-filtration	 step	 helps	 remove	
aggregates	 and	 isolate	 hexamers.	We	 use	 the	 same	 protocol	 for	 purifying	 human	






septin	 hexamers	 (the	 same	 applies	 to	 Drosophila	 septins	 by	 analogy).	 See	 text	 for	 details.	
Understanding	the	principles	of	septin	complex	assembly	is	an	intense	topic	of	investigation,	and	the	
presence	and	stability	of	intermediate	complexes	has	not	been	fully	documented.	We	show	selected	
populations	 of	 human	 septin	 complexes	 in	 the	 cell	 lysate	 (monomers,	 homo-	 and	 heterodimers,	
heterotrimers	 and	hexamers)	 based	on	 the	 isolation	 and	 characterization	of	 such	 recombinant	 and	
native	complexes	(Kim,	Froese,	Xie,	&	Trimble,	2012;	Mavrakis	et	al.,	2014;	Sellin	et	al.,	2011;	Serrao	




































complexes.	 Measure	 the	 protein	 concentration	 after	 each	 purification	 step	 using	
absorbance	 measurements	 at	 280	 nm	 for	 monitoring	 protein	 loss	 during	 the	
purification	process.	


















300	mM	KCl,	 5	mM	MgCl2,	2.5	 mM	 desthiobiotin.	 Collect	 1-mL	 fractions.	 Pool	 all	
fractions	contained	in	the	elution	peak	(typically	5	mL).	
7.	 Load	 the	pooled	 fractions	 to	 a	 Superdex	 200	HiLoad	16/60	 column	equilibrated	
with	1.2	CV	of	50	mM	Tris-HCl	pH	8,	300	mM	KCl,	5	mM	MgCl2,	5	mM	DTT.	Elute	
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with	 1.2	 CV	 of	 the	 same	 buffer.	 Elute	 for	 0.25CV	 before	 collecting	 1-mL	 fractions.	
Pool	 the	 fractions	 corresponding	 to	 the	 elution	 peak	 (typically	 10	 mL)	 and	
concentrate	 using	 passivated	 Amicon	 concentrators	 (see	 below).	 Measure	 the	
concentration	 using	 the	 elution	 buffer	 as	 a	 blank,	 prepare	 10-	 or	 20-µL	 aliquots,	





nm.	 We	 compute	 extinction	 coefficients	 from	 the	 amino	 acid	 sequences	 using	











to	 significant	 yield	 loss.	 To	 improve	 recovery	 of	 septins	 during	 the	 concentration	
step,	we	passivate	the	concentrators	by	treating	them	with	5%	v/v	Triton	X-100.		
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water	 and	 finally	 spin	 through	 for	 5	min	 at	 4,500	 g.	 The	 passivated	 device	 is	 now	
ready	to	use.		
4.	 Add	 gel	 filtration	 elution	 buffer	 and	 spin	 through	 for	 5	 min	 at	 4,500	 g	 to	
equilibrate	the	concentrator	membrane.	
5.	 Add	 the	 gel	 filtration	 eluate	 and	 spin	 through	 until	 reaching	 the	 desired	








Studies	 Hybridoma	 Bank),	 rat	 anti-DSep1-95	 (1:500)	 (Mavrakis	 et	 al.,	 2014)	 and	
guinea	pig	anti-DSep2-92	(1:500)	(Mavrakis	et	al.,	2014).	For	human	septins,	we	use	
goat	 anti-hSep2	 (1:500,	 Santa	 Cruz	 Biotechnology,	 sc-20408),	 rabbit	 anti-hSep6	
(1:500,	Santa	Cruz	Biotechnology,	sc-20180)	and	rabbit	anti-hSep7	(1:200,	Santa	Cruz	
Biotechnology,	 sc-20620).	 For	 both	 Drosophila	 and	 human	 septins,	 we	 use	 HRP-
conjugated	 anti-Penta-His	 (1:10,000,	 Qiagen)	 and	 HRP-conjugated	 anti-Strep-tag	
(1:10,000,	AbD	Serotec).	
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hSep2	 antibodies	 recognize	 the	 N-terminus	 of	 hSep2,	 whereas	 hSep6	 and	 hSep7	
antibodies	 recognize	 the	 C-terminus	 of	 hSep6	 and	 hSep7,	 respectively.	 Pnut	
antibodies	 recognize	 the	 N-terminus	 of	 Peanut	 (Mavrakis	 et	 al.,	 2014),	 whereas	
DSep1-95	and	DSep2-92	antibodies	recognize	the	N-terminus	of	DSep1	and	DSep2,	
respectively	(Mavrakis	et	al.,	2014).	We	combine	these	antibodies	with	the	His-	and	
Strep-tag	 antibodies	 that	 recognize	N-	 and	 C-termini,	 respectively,	 to	 examine	 the	
integrity	of	each	septin	in	the	prep	by	Western	blot.	
The	purity	of	 the	septin	preps	can	be	 further	 tested	by	mass	spectrometry	both	 in	




Finally,	 we	 evaluate	 the	 quality	 of	 each	 septin	 preparation	 in	 terms	 of	 oligomer	
composition	 and	 hexamer	 content	 by	 transmission	 electron	microscopy	 combined	







detailed	 above.	 Co-express	 His6-DSep1	 with	 mEGFP-DSep2/Pnut-Strep	 to	 produce	












form,	 to	 ensure	 that	 hexamers	 are	 still	 polymerization-competent	 after	 labeling.	
Different	 septin	 complexes	 and	 septins	 from	 different	 species	 can	 polymerize	 to	




• purified	 septins	 in	50	mM	Tris-HCl	pH	8,	 300	mM	KCl,	 5	mM	MgCl2,	 5	mM	DTT	
(septin	buffer)	









the	 septin	buffer	 (Tris	and	DTT),	dialyze	 septins	 into	50	mM	Hepes-KOH	pH	8,	300	
mM	KCl,	5	mM	MgCl2.	
2.	Prepare	a	20	mM	stock	of	the	NHS	ester	in	DMSO	immediately	before	starting	the	






with	 1.5-mL	 tubes).	 The	 resulting	 pellet	 will	 be	 yellow-greenish	 confirming	 the	
reaction	with	Alexa	Fluor	488	(AF488)	NHS	esters.	









3.	 Elute	 with	 3.5	 mL	 septin	 buffer	 in	 0.5-mL	 fractions.	 AF488-septins	 elute	 in	
fractions	2-4	(1.5	mL	in	total).	Measure	the	protein	concentration	and	calculate	the	
degree	of	labeling.	Use	the	values	provided	by	the	manufacturer	for	the	dye	(λmax,	ε,	







microscopy,	 we	 design	 flow	 cells	 having	 6	 rectangular	 shaped	 channels	 with	
approximate	dimensions	of	22	mm	in	length,	2.5	mm	in	width	and	0.1	mm	in	height	

































NH4OH	and	 then	slowly	add	one	part	H2O2.	Gently	mix	 the	 solution	by	moving	 the	
Teflon	 rack	 up-and-down	 in	 the	 beaker.	 Once	 the	 piranha	 solution	 reaches	 a	
temperature	 of	 60°C,	 bubbles	 form	 in	 the	 solution,	 indicating	 an	 active	 reaction.	
Allow	the	solution	to	react	for	30	min.		
Tip:	 The	 base-piranha	 solution	 is	 a	 dangerous	 reaction,	 thus	 wear	 gloves	 and	
safety	goggles,	and	avoid	spills.		





5. To	activate	 the	hydroxyl	groups	on	glass	 substrates	 for	 the	 silanization	 reaction,	










8. Transfer	 the	 slides	 and	 coverslips	 into	 the	 glass	 beaker	 filled	with	 the	 DDS/TCE	
solution	and	incubate	for	1	h,	without	stirring.	
Note:	Carefully	dispose	used	DDS/TCE	 solution	according	 to	 local	 laboratory	 safety	
regulations.	
9. Transfer	 the	 slides	 and	 coverslips	 in	 a	 glass	 beaker	 filled	 with	 methanol	 and	
sonicate	for	15	min	in	a	bath	sonicator.	




















7. Place	 the	 assembly	 on	 a	 hot	 plate	 set	 at	 120°C.	 Once	 the	 Parafilm	 strips	 are	




Tip:	 While	 melting	 the	 assembly,	 air	 bubbles	 can	 appear	 at	 the	 contact	 surface	
between	 the	 Parafilm	 strips	 and	 the	 glass	 coverslip.	 Apply	 gentle	 pressure	 on	 the	






Note:	 Silanized	 glass	 substrates	 are	 hydrophobic,	which	 hampers	 inflow	of	 sample	
solutions.	 We	 thus	 treat	 channels	 with	 Pluronic	 F-127	 to	 render	 the	 surface	
hydrophilic	enough	to	be	able	to	flow	in	the	aqueous	solution.	














l	Protocatechuate	 acid	 (PCA)	 (03930590-50MG,	 Sigma),	 100	 mM	 in	 water	 and	
adjusted	to	pH	9	using	NaOH,	-80°C	











G-actin	 is	purified	 from	rabbit	 skeletal	muscle	by	a	 standard	procedure	 including	a	
final	gel	filtration	step	on	a	HiPrep	26/60	Sephacryl	S-200	HR	column	(GE	Healthcare)	
(Pardee	&	Spudich,	1982).	G-actin	 is	 stored	at	 -80°C	 in	G-buffer	 (2mM	Tris-HCl,	pH	
7.8,	0.2	mM	Na2ATP,	0.2	mM	CaCl2,	and	2	mM	DTT).	G-actin	is	fluorescently	labeled	
with	Alexa	 Fluor®	594	 carboxylic	 acid,	 succinimidyl	 ester	 (AF594-G-actin)	 (Soares	 e	
Silva	et	al.,	2011)	and	is	also	stored	at	-80°C	in	G-buffer.	Dark	and	fluorescent	septins	
























photobleaching	due	 to	 the	 reactions	of	 the	 triplet	 states	with	oxygen	 free	 radicals	




exerts	 an	 entropic	 force	 pushing	 actin-septin	 filaments	 towards	 the	 surface	 to	
facilitate	observation	by	TIRF	imaging.	However,	we	recommend	to	use	at	most	0.2%	




Here	 we	 describe	 a	 procedure	 to	 prepare	 samples	 in	 which	 actin	 and	 septins	 co-
polymerize.	 To	 visualize	 actin	 and	 septins,	we	dope	actin	with	AF594-G-actin	 (10%	
molar	 label	 ratio)	 and	 septins	with	AF488-septins	 or	GFP-septins	 (10%	molar	 label	

















Tip:	We	 typically	dilute	 the	septin	 solution	6-fold	 into	 the	 final	mixture	 in	order	 to	
obtain	50	mM	KCl	 from	the	septin	buffer.	When	performing	a	 series	of	 samples	 in	
which	 actin	 concentration	 stays	 constant	 but	 septin	 concentration	 varies,	 one	 can	






solutions	 thoroughly	by	aspirating	up	and	down	3	 times	and	 immediately	 load	 the	
mixed	solution	into	one	flow	channel.		
Note:	 Given	 that	 G-actin	 polymerizes	 into	 F-actin	 immediately	 when	 mixed	 with	
salts,	it	is	important	to	perform	the	above	step	quickly.		







To	prepare	septin	 filaments	 in	 the	absence	of	actin	 (Figure	6),	we	 follow	the	same	
procedure	as	above,	but	replace	the	G-actin	solution	with	G-buffer.	
	
For	 experiments	 with	 preformed	 actin	 filaments	 at	 1 µM,	 we	 first	 pre-polymerize	
actin	 at	 24 µM	 (10%	 molar	 label	 ratio)	 in	 F-buffer	 for	 at	 least	 1	 hour	 at	 room	
temperature	in	the	dark.	We	then	follow	the	same	procedure	as	above,	but	prepare	




Figure	 5.	 TIRF	 images	 of	 in	 vitro	 reconstituted	 actin-septin	 co-assembly,	 showing	 AF594-actin	with	
10%	molar	 label	 ratio	 (left),	 AF488-Drosophila	 septins	with	 10%	molar	 label	 ratio	 (middle)	 and	 the	











We	 image	 actin-septin	 filament	 assembly	 near	 the	 surface	 of	 the	 passivated	
coverslips	 by	 TIRF	 microscopy,	 which	 is	 ideally	 suited	 to	 provide	 a	 high	 signal-to-
noise	ratio	for	 in	vitro	surface	assays.	Samples	are	 imaged	with	a	Nikon	Apo	TIRF	×	
100/1.49	NA	oil	objective	mounted	on	an	Eclipse	Ti	microscope	(Nikon)	using	491	nm	
and	 561	 nm	 laser	 lines	 and	 imaged	 with	 a	 QuantEM	 512SC	 EMCCD	 camera	
(Photometrics).	We	 generally	 use	 exposure	 times	 of	 100-200	ms	 and	optimize	 the	






























pnCS	 vectors	 of	 the	 pET-MCN	 series	 (Diebold	 et	 al.,	 2011).	 Here	 this	 strategy	 is	 used	 for	 the	
generation	of	 recombinant	Drosophila	 (DSep1-DSep2-Pnut)	and	human	 (hSep2-hSep6-hSep7)	 septin	
hexamers.	See	text	for	details.		
Figure	2.	Schematic	overview	of	the	two-tag	purification	scheme	for	 isolating	stoichiometric	human	
septin	 hexamers	 (the	 same	 applies	 to	 Drosophila	 septins	 by	 analogy).	 See	 text	 for	 details.	
Understanding	the	principles	of	septin	complex	assembly	is	an	intense	topic	of	investigation,	and	the	
presence	and	stability	of	intermediate	complexes	has	not	been	fully	documented.	We	show	selected	
populations	 of	 human	 septin	 complexes	 in	 the	 cell	 lysate	 (monomers,	 homo-	 and	 heterodimers,	
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heterotrimers	 and	hexamers)	 based	on	 the	 isolation	 and	 characterization	of	 such	 recombinant	 and	
native	 complexes	 (Kim	 et	 al.,	 2012;	 Mavrakis	 et	 al.,	 2014;	 Sellin	 et	 al.,	 2011;	 Serrao	 et	 al.,	 2011;	
Sheffield	 et	 al.,	 2003;	 Sirajuddin	 et	 al.,	 2007;	 Sirajuddin	 et	 al.,	 2009;	 Zent	 et	 al.,	 2011;	 Zent	 &	
Wittinghofer,	2014).	
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